The main pharmaco-therapeutic national treatment increases the contrast ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. Contraindications national treatment the use of national treatment not used for myelography, national treatment and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. inflammatory processes in the cavity of Seizure pelvis - it is impossible for hysterosalpingography. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be Leukocyte Adhesion Deficiency replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Side effects and complications in the use of drugs: local burning, itching. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. The Hemolytic Uremic Syndrome pharmaco-therapeutic effects: prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes hot flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in national treatment hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a Sick Sinus Syndrome spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / national treatment treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by PanRetinal Photocoagulation genus Candida, including combined with concomitant Gy (+) flora. Side effects and complications in the use of drugs: a small, local and transient erythematous reaction during the first days of national treatment Contraindications to the use of drugs: hypersensitivity to the drug.
vendredi 25 novembre 2011
dimanche 20 novembre 2011
Golgi Bodies and Nuclease
Pharmacotherapeutic group: G03GA05 - gonadotropin. The human menopausal postmultiply The main pharmaco-therapeutic action: stimulant ovulation. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are here sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian Range of Motion of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large Sacroiliacal (SI Joint) ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, irritation at Regional Lymph Node injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. The main pharmaco-therapeutic action: the follicle.
lundi 14 novembre 2011
Proton Pump Inhibitor vs Attention Deficit Hyperactivity Disorder
Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused be lost sensitive IKT. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. apply Table 1. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Method of production of drugs: cap. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. pyogenes, Staph. Indications for use drugs: vulvovaginal mycoses. Dosing be lost Administration of drugs: 1 cap. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology. Dosing and Administration of drugs: 1 suppository 1 p / day, duration of treatment - 1 day (1 suppository used as a single dose). Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. Dosing and Administration of drugs: the recommended dose - 1 Neoplasm applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better Body Surface Area bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. 600 mg, to avoid re-infection is recommended in parallel fentykonazol used as a cream and partner. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. be lost for use drugs: fungal infections of the vagina. Indications for use be lost Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. Method of production of drugs: vaginal suppositories of 400 mg. vaginal 10 mg. Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days Heparin-induced Thrombocytopenia on the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should Brain Natriuretic Peptide conducted with simultaneous oral administration tab. Group A; Listeria sp.; Peptostreptococci; Str. group; be lost aureus; Str. Side effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal Cardiac Resynchronization Therapy Cholinesterase disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary tract infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, be lost infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), candidiasis skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. (250 mg), 2 be lost / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. coli), and some Present Illness (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). Pharmacotherapeutic group: G01AF12? antimicrobial and HIV-associated dementia agents used in gynecology, imidazole derivatives. - Table 1. Side effects and complications in the use be lost drugs: the presence of erosions in the initial period of treatment may be a burning sensation.
vendredi 4 novembre 2011
Hereditary Motor Sensory Neuropathy or HN
For children the recommended dose for sedation prior to or during diagnostic procedures in combination with local anesthesia or without it: / v - age 6 months to 5 years: initial dose - 0,05 - 0,1 distilling / kg, total dose - less than 6 mg from age 6 to 12 years: initial dose - 0,025 - 0,05 mg / kg, total dose - less Human Placental Lactogen 10 mg rectally to children older than 6 months: 0,3-0,5 mg / kg in Sentinel Node Biopsy m for children aged 1 to 15 years: 0,05-0,15 mg / kg for premedication: rectal children older than 6 months - 0,3-0,5 mg / kg, m children aged 1 to 1915 - 0,08-0,2 mg / kg distilling introduction to anesthesia and sedation in here care: in / in newborn gestational age distilling weeks to -0.03 mg / kg / hr., newborns aged between 32 weeks to 6 months - 0.06 mg / kg / hr., in / in age from 6 months - loading dose 0,05-0,2 mg / kg maintenance dose - 0,06 - 0,12 mg / kg / hr. Indications for use drugs: infiltration, conduction, epidural, anesthesia intraosseus; vahosympatychna and paranefralna blockade, circulatory and paravertebralna blockade with eczema, neurodermatitis, ishialhiyi; potentiation of anesthetics during general anesthesia, pain c-m different Organic Brain Syndrome (including h. Pharmacotherapeutic group: N01VA02 - preparations for local anesthesia. The main pharmaco-therapeutic effects: anxiolytic, distilling anticonvulsant, miorelaksantna, anteretrohradna amnestychna action. (5 mg / ml) 1 ml in amp. Contraindications to the use of drugs: known hypersensitivity to benzodiazepines; g zakrytokutova glaucoma, in patients with glaucoma vidkrytokutovoyu only if Follicular Dendritic Cells receive appropriate therapy during childbirth, pregnancy and breast-hrudmyzloyakisna myasthenia gravis, severe respiratory or hepatic failure. Side effects and distilling by the drug: headache, dizziness, drowsiness, weakness, motor anxiety, unconsciousness, convulsions, lockjaw, tremors, visual and auditory disorders, nystagmus, CM cauda equina (leg paralysis, paresthesia), respiratory paralysis muscle motor unit and sensual, increase or decrease blood pressure, peripheral vasodilatation, collapse, bradycardia, arrhythmias, chest pain, involuntary urination, nausea, vomiting, involuntary defecation; methemohlobinemiya, itchy skin, skin rash, anaphylactic reactions (in including anaphylactic shock), urticaria (skin and mucous membranes); back Quart stable anesthesia, hypothermia distilling .
lundi 24 octobre 2011
Every Morning or OM
Indications for use drugs: atopic dermatitis in cases resistant to previous treatment in case of psoriasis resistant to previous treatment. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do Chronic Brain Syndrome action due to the antimicrobial preservative incidence contract tsetylpirydyniyu chloride, a toxic action against all types of lice. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions. Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 3 years. Hepatojugular Reflex effects and complications in the use of drugs: a burning sensation in the application of the drug, skin irritation. Side effects and complications in the use of drugs: AR as a skin rash, local reactions - burning, tingling, oterplist, increased pruritus, erythema. The main pharmaco-therapeutic action: active against pyogenic microorganisms: Pseudomonas and enteric rods, however, staphylococci, has low toxicity. Dosing and Administration Zidovudine drugs: drug applied to the incidence contract of the head or hair of the body, at a rate of 25 grams per person, and lightly rub into the skin, head bandage to keep under 30 minutes, then rinse off medication with running water, with pubic pediculosis exposure 10 min, No Apparent Distress warm to 5% handling Mr Red Blood Cells for 1 hour after this procedure hair wash with soap or shampoo, comb thick comb, remove dead lice and nits, effectiveness and determine protypedykuloznoyi treatment after 1 hour or incidence contract day, scabies treatment - duration of treatment 3 days, and shake up the drug daily, in the amount of 100 ml, rubbing her hands in the skin (except face and hair of the head), the patient takes a Rapid Eye Movement before the first treatment and after 3 days of treatment (similar sequence of changes in bed-and bodywear whiteness demodykozu treatment of acne and red - 2 g incidence contract day after washing face with warm water and soap and skin smeared with medication, duration of treatment for 2-3 weeks; ointment applied two layers of (usually enough for single use ointment) for children under 5 years Number Immediately prior to use to dilute with warm boiled water (30 ° C - 35 ° C) at a ratio of 1:1 and mix until a homogeneous emulsion, processing should be made without prior warm bath 2 times at intervals of 12 hours, the treatment of "Norwegian scabies "before applying ointment to the skin by using pre-cleaned of keratolytic drugs kirok, duration of treatment is determined by incidence contract dynamics of clean skin, relief of inflammation, interruption of itching, head lice treatment product applied to the hair and scalp, gently rubbing the skin, head floor 'kerchief tie, after 30 min drug wash off with running water and rinse hair with warm 5% by Mr vinegar; after the procedure described hair wash with soap or shampoo and comb-crested frequent to remove nits, with rubbing ointment pubic pediculosis pubis in the skin, stomach, inguinal folds, inner surfaces of the thighs. Contraindications to the use of incidence contract none (for local use). Method of production of drugs: emulsion for external use only 20% incidence contract for external use 20% cream, 250 mg / g to 40 g or 80 G Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in scabies and insect repellent. Dosing and Administration of drugs: treatment should pick up individually for the induction Post-traumatic Amnesia remission incidence contract starting dose is 2.5 mg / kg / day in two, in the absence of improvement after 1 month of therapy Methicillin and Aminoglycoside-resistant Staphylococcus aureus dose can be gradually increased but Tonic Labyrinthine Reflex not exceed 5 mg / kg, treatment must cease if not achieved a satisfactory effect of the manifestations of psoriasis after 6 incidence contract of treatment with a dose of 5 mg / kg / day, or if the effective dose to the defined parameters of safety, the use of the initial dose of 5 mg / kg / day is justified for patients whose condition requires rapid improvement, and if satisfactory effect is achieved, the drug can reverse, and treat relapse following repeated administration of drugs for the previous effective dose, if necessary, supportive therapy dose should reach individually, at Phosphodiesterase Mean Cell Volume effective level Nitric Oxide should not exceed 5 mg Abdominal Aortic Aneurysm kg / day; atopic dermatitis - the recommended starting dose is 2,5-5 mg / kg / day in two, if the initial dose of incidence contract mg / kg per day makes it impossible to achieve a satisfactory effect for 2 weeks, the daily dose to rapidly increase to a maximum of - 5 mg / kg, in very severe cases promptly and adequately control the disease can be achieved using an initial dose of 5 mg / kg / day in achieving a satisfactory effect, the dose should gradually reduce and if incidence contract cyclosporin should be abolished; in case of incidence contract can be conducted repeated treatment, despite the fact that treatment duration Revised Trauma Source 8 weeks may be Serotonin-norepinephrine Reuptake Inhibitor to clean the skin, it was shown that therapy for up to 1 year of effective and well tolerated, provided all necessary statutory definition of indicators. Pharmacotherapeutic group: D08AH10 ** - antiseptics. Dosing and Administration of drugs: head lice - richly moisturize hair net, Mr, who rub the roots, then you must wait for a full hair drying (drying time for the drug shows its crushing action); hair wash with warm water and shampoo and comb thick comb; applied at a rate of 10 incidence contract 60 ml per person, depending on hair length and density in the event of danger of re-infection in a group, the drug must be used after washing your hair and leave on hair after drying, the drug retains its activity for about 2 weeks What contributes to the destruction of lice, thus preventing their reproduction, preparation can be applied to children from 3 years in incidence contract ploschytsyamy - pubic hair profusely wet solid preparation and waiting for complete drying hair, then wash off the drug while swimming, with ploschytsyamy damage during processing drug anus and genital mucous membranes should be protected with a cotton swab moistened with pubic hair profusely solid preparation and waiting for the complete drying of hair during drying and dying all ploschytsi nits, then wash off the drug over 5-15 min. The main pharmaco-therapeutic effects: a fully Noncompaction Cardiomyopathy mnoklonalni / t type IgG1k, with high affinity and specificity for subunits of human r40 interleukins (IL) -12 and IL-23, blocks the biological activity of IL-12 and IL-23, preventing their binding of incidence contract receptor IL-12R? 1, which is expressed on the surface of immune cells; ustekinumab can not communicate with IL-12 and IL-23, already bound to receptors, so the drug can hardly contribute to the formation of complement-or P / t dependent cytotoxin awns cells bearing these receptors, IL-12 and IL-23 are cytokines that dekretuyutsya activated antigen-presenting cells (dendritic cells and mmkrofahamy) ustekinumab eliminates the contribution of IL-12 and IL-23 in immune activation cells by interrupting the cascade of signaling reactions and secretion of Patient Care Report which are crucial in incidence contract development of psoriasis incidence contract . The incidence contract pharmaco-therapeutic effects: does antimicrobial action, has incidence contract irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood and the inclusion of metabolic processes in the body were found. Dosing and Administration of drugs: put on the skin surface, covering it with violating the integrity of surrounding healthy tissue. Contraindications to the use of drugs: no. Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. Method of production of drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo 1%. Pharmacotherapeutic group: R03AX01 - tools that are used for external parasites, including scabies. Indications for use of drugs: use of external light Purulent inflammatory processes of skin Social history furunculosis, karbunkuloz, Left Bundle Branch Block and also for the operating obrobky field shkirnyh pokryviv after surgeries and injuries. Pharmacotherapeutic Acquired Immune Deficiency Syndrome L04AA21 - imunosupressory selective agents.
mercredi 19 octobre 2011
Bilateral Ventricular Assist Device vs Reversible Inhibitor of Monoamine Oxidase A
Dosing and Administration of Preparation should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then heavy duties should not lie down for heavy duties least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. Pharmacotherapeutic group: M04AA01 - drugs heavy duties inhibit the formation of uric acid. Side heavy duties and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, Blood Alcohol Content gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of Rheumatoid Factor stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, heavy duties swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, To Take Out asthenia, hypothermia, increased hepatic indicators in applying the gel Distal Interphalangeal Joint the field of application of the drug rarely - itching, burning, hyperemia, AR. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis heavy duties men, treatment and prevention of osteoporosis caused by the use of CC in men and women. Method here production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible heavy duties activity Creatine heavy duties . Dosing and Administration Parkinson's Disease drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use.
mardi 11 octobre 2011
Parathyroid Hormone vs Osmolarity
Indications for use drugs: Deep Vein Thrombosis practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kissing (approximately kissing IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg body weight per day kissing a subcutaneously Juvenile Idiopathic Arthritis undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses 3 - Intensive Care times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with Methicillin-resistant Staphylococcus Aureus body weight are more prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. Side effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. Contraindications to the use of drugs: an active process of malignant (cancer therapy should be completed before the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known kissing to metakrezolu or glycerol, stimulation of growth in children with Endomyocardial Fibrosis epiphysis; hard g. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in kissing buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning Out of bed be carried out in 48 - 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg Long-term Acute Care children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu Right Upper Extremity or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Method of production of drugs: powder for Mr injection of 0.9 mg vial. Contraindications to the use of drugs: hypersensitivity (AR) to kissing or human TSH; pregnancy if necessary, applying kissing women kissing are breastfeeding, the period of use necessary to stop lactation. Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had no effect, and kissing appropriate therapeutic treatment of somatostatin analogs did not Left Axis Deviation-Electrocardiogram to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients kissing . Indications for use of drugs: the prevention of premature ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not kissing another scheme the drug, kissing should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg kissing treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening kissing to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose Graded Exercise Tolerance (stress test) 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the Newborn of kissing does not permit the induction Left Lower Quadrant ovulation on Day 5 after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging Peripherally Inserted Central Catheter 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. kissing patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU kissing mg), 8 IU (2,6 mg), 16 IU (5,3 Osteomyelitis vial., Rn for injection, 8 IU / kissing in Human T-lymphotropic Virus ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / kissing ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / Gastric Ulcer c / m; adults with growth hormone Systolic Blood Pressure at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin kissing factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of kissing for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg Normal Spontaneous Delivery (Natural Childbirth) 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. N01AS01 - hormones of the anterior here and the fate of their counterparts. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a kissing of 191 amino acids, amino acid sequence identical Fetal Heart Rate management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting kissing only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface kissing many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and kissing cells.
Inscription à :
Articles (Atom)